Tomorrow, Johnson & Johnson gets its day in the limelight at a Congressional hearing on the company’s ongoing manufacturing woes and most recent product recall. The company is offering up its Worldwide Chairman of the Consumer Group, Colleen Goggins, as the official scapegoat for the whole affair.
Meanwhile, over at the official blog, the company has finally offered a shell plan for what it intends to do about this whole affair. While nearly two years too late, it is a positive step for the company. I’ve been highly critical of J&J recently, but perhaps the company is finally turning a corner.
Will it be enough to avoid a consent decree with the FDA? Only time will tell.
